Shareholders fretting about the unhealthy impact of Obamacare on the US drugmakers have been suffering from hypochondria Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,